WATER-SOLUBLE DERIVATIVES OF GOSSYPOL
WATER-SOLUBLE DERIVATIVES OF GOSSYPOL
批准号:
3499299
负责人:
HARRY G PARS
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-01 至 1986-11-15
中文摘要
一种有效的口服男性抗生育药物,既无毒又
可逆,目前不可用。棉酚,最有希望的
非类固醇男性抗生育铅,具有不可接受的狭窄
治疗比率。
我们建议可以通过改变治疗方案来提高治疗比例。
水溶作用的药代动力学和生物利用度。
因此,几种精心挑选的棉酚水溶性衍生物
都会做好准备。然后将在体外对这些化合物进行这两种测试
杀精活性和体内抗生育活性。体内试验
将从疗效和毒性两方面进行评估。
一种与棉酚相同药效的化合物的鉴定
没有毒性的影响将为进一步的研究提供基础
最终开发一种安全有效的男性抗生育药物
探员。
英文摘要
An effective oral male antifertility agent, which is both non-toxic and
reversible, is not currently available. Gossypol, the most promising
non-steroidal male antifertility lead, has an unacceptably narrow
therapeutic ratio.
We propose that the therapeutic ratio may be improved by alteration of the
pharmaco-kinetics and bioavailability through water-solubilization.
Accordingly, several carefully chosen water-soluble derivatives of gossypol
will be prepared. These compounds will then be tested for both in vitro
spermicidal activity and in vivo antifertility activity. The in vivo tests
will be evaluated both in terms of efficacy and toxicity.
The identification of a compound with the same efficacy as gossypol but
without the toxic effects would provide the basis for further study leading
to the eventual development of a safe and effective male antifertility
agent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CANNABINOIDS AS ANTIHYPERTENSIVE AGENTS
-
批准号:3500707
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1985
-
负责人:HARRY G PARS
-
依托单位:
PHASE II: DEVELOPMENT OF MENABITAN, A NOVEL ANALGESIC (1
-
批准号:3507739
-
项目类别:
-
资助金额:$19.02万
-
财政年份:1983
-
负责人:HARRY G PARS
-
依托单位: